{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:01Z","timestamp":1787010181078,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,6]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Infections due to multidrug-resistant (MDR)\n                      <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>\n                      are strongly associated with poor outcomes, including prolonged hospitalization and an increased risk of mortality. Antimicrobial options for the treatment of severe infections due to MDR\n                      <jats:italic toggle=\"yes\">P aeruginosa<\/jats:italic>\n                      are quite limited, and treatment remains challenging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 65-year-old woman presented to our orthopedic clinic with a 3-month history of progressive pain and stiffness in her left knee. Her primary care provider administered a hyaluronic acid injection, which unfortunately resulted in worsening symptoms. Subsequent treatment included a 1-month course of intravenous gentamicin and ceftriaxone, which failed to alleviate her symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>\n                      MDR\n                      <jats:italic toggle=\"yes\">P aeruginosa<\/jats:italic>\n                      septic arthritis of the knee. The culture isolate was tested for susceptibility to multiple antibiotics. Magnetic resonance imaging evaluations were conducted, showing notable erosive and osteolytic changes around the joint surfaces that had progressed significantly.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent arthroscopic irrigation and synovectomy. The treatment regimen included a combination of intravenous colistin and piperacillin\/tazobactam administered over a 6-week period. Total knee arthroplasty was performed 6 months later without additional antibiotic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Patient\u2019s knee condition remained continuously stable without abnormal findings of inflammation. The patient\u2019s knee range of motion increased 0 to 125\u2009degrees, her pain almost disappeared, and she was able to maintain activities of daily life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores the challenges of managing infections with MDR organisms in complex clinical scenarios, emphasizing the need for timely intervention and appropriate antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000039462","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:08:56Z","timestamp":1730866136000},"page":"e39462","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Rapid bone destruction caused by multidrug-resistant Pseudomonas aeruginosa septic arthritis: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Sung Cheol","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"In","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Mohammed","family":"AlShammari","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, King Abdulaziz Air Base Hospital, Ministry of Defense, Dhahran, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1374-9964","authenticated-orcid":false,"given":"Man Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/BOR.0b013e3283036975","article-title":"Septic arthritis: current diagnostic and therapeutic algorithm.","volume":"20","author":"Mathews","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European Society of Intensive Care Medicine).","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002512-200926050-00001","article-title":"Current treatment of pseudomonal infections in the elderly.","volume":"26","author":"Pappas","year":"2009","journal-title":"Drugs Aging"},{"key":"R4-20250505","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/antibiotics12020399","article-title":"Evidence-based treatment of Pseudomonas aeruginosa infections: a critical reappraisal.","volume":"12","author":"Karruli","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R5-20250505","first-page":"3357","article-title":"Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus \u03b2-lactams.","volume":"70","author":"Ribera","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00207-10","article-title":"Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.","volume":"54","author":"Tam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1017\/S0950268810003055","article-title":"Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.","volume":"139","author":"Tumbarello","year":"2011","journal-title":"Epidemiol Infect"},{"key":"R8-20250505","doi-asserted-by":"crossref","first-page":"e01759","DOI":"10.1128\/AAC.01759-19","article-title":"Predictors of mortality in bloodstream infections caused by Pseudomonas aeruginosa and impact of antimicrobial resistance and bacterial virulence.","volume":"64","author":"Recio","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"e00031","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections.","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jbspin.2014.02.004","article-title":"Is ceftriaxone 2\u2009g once daily a valid treatment option for osteoarticular infections due to Staphylococcus spp., Streptococcus spp., and gram-negative rods?","volume":"81","author":"Coiffier","year":"2014","journal-title":"Joint Bone Spine"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/art.1780381215","article-title":"Risk factors for septic arthritis in patients with joint disease. A prospective study.","volume":"38","author":"Kaandorp","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.58.4.214","article-title":"Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991.","volume":"58","author":"Weston","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1053\/j.jrn.2020.05.009","article-title":"Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference.","volume":"30","author":"Levey","year":"2020","journal-title":"J Ren Nutr"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4055\/cios21214","article-title":"Evaluation of appropriateness of the reimbursement criteria of Korean health insurance review and assessment service for total knee arthroplasty.","volume":"15","author":"Kim","year":"2023","journal-title":"Clin Orthop Surg"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43019-022-00132-8","article-title":"Past, present, and future of cartilage restoration: from localized defect to arthritis.","volume":"34","author":"Lee","year":"2022","journal-title":"Knee Surg Relat Res"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43019-023-00194-2","article-title":"Evaluation of the changes in incidence and patient age of knee arthroscopy along with changes in time between knee arthroscopy and arthroplasty between 1998 and 2018: a nationwide register study.","volume":"35","author":"Ponkilainen","year":"2023","journal-title":"Knee Surg Relat Res"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/ar2","article-title":"A possible cause of joint destruction in septic arthritis.","volume":"1","author":"Krieg","year":"1999","journal-title":"Arthritis Res"},{"key":"R19-20250505","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.3928\/01477447-20160606-05","article-title":"Predictors of septic arthritis in the adult population.","volume":"39","author":"Borzio","year":"2016","journal-title":"Orthopedics"},{"key":"R20-20250505","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.idc.2017.01.001","article-title":"Septic arthritis of native joints.","volume":"31","author":"Ross","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"R21-20250505","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1099\/0022-1317-51-7-620","article-title":"Community-acquired Pseudomonas aeruginosa sacro-iliitis in a previously healthy patient.","volume":"51","author":"Calza","year":"2002","journal-title":"J Med Microbiol"},{"key":"R22-20250505","doi-asserted-by":"crossref","first-page":"106262","DOI":"10.1016\/j.ijscr.2021.106262","article-title":"Case report: management of septic knee arthritis with Pseudomonas aeruginosa by arthroscopic debridement and lavage with diluted povidone iodine.","volume":"85","author":"Daradkeh","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"R23-20250505","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/AAC.01015-06","article-title":"Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.","volume":"51","author":"Hachem","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-20250505","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jiph.2022.08.020","article-title":"Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: a multicenter retrospective study.","volume":"15","author":"Hakeam","year":"2022","journal-title":"J Infect Public Health"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3343\/alm.2016.36.2.138","article-title":"In vitro synergistic effects of antimicrobial combinations on extensively drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates.","volume":"36","author":"Lee","year":"2016","journal-title":"Ann Lab Med"},{"key":"R26-20250505","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R27-20250505","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2012.09.016","article-title":"Difficult-to-treat gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin.","volume":"41","author":"Valour","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"R28-20250505","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1128\/AAC.05298-11","article-title":"Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic\/pharmacodynamic model.","volume":"55","author":"Bergen","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:00:58Z","timestamp":1746460858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":28,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039462","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}